Fortis Healthcare showcased an improvement in net debt to EBITDA, standing at 0.29 compared to 0.44 annually for Q2 FY24 and Q2 FY23
Read More
The Core EBITDA recorded a commendable 35 per cent YoY growth, reaching Rs 1,100 crore
Read More
The company, operating 713 beds primarily in the Delhi NCR region, reported a consolidated gross revenue of Rs. 2,376 million, marking a substantial 21.0 per cent increase
Read More
In Q2 FY24, HCG achieved consolidated income from operations (Revenue) of Rs 4,869 million, marking a substantial 15.9 per cent year-on-year (YoY) growth and a 5.7 per cent quarter-on-quarter (QoQ) growth
Read More
The company reported a profit after tax (PAT) of Rs 1,223 million in Q2 FY24
Read More
The transaction, valued at Rs 3,660 million, inclusive of working capital, signifies a favourable multiple of 4 times on Revenues and 22 times on EBITDA
Read More
For the second quarter of the fiscal year 2024, Revenue from Operations reached a remarkable Rs. 1,713 million, representing a substantial 34 per cent year-on-year (YoY) increase
Read More
In the second quarter, Alembic reported a notable 8 per cent increase in net sales, amounting to Rs. 1,595 crores while its net profit for the quarter reached Rs. 137 crores
Read More
